PETER KAZUO KAISER

Summary

Publications

  1. ncbi request reprint Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8
    Peter K Kaiser
    Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Graefes Arch Clin Exp Ophthalmol 244:1132-42. 2006
  2. ncbi request reprint Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases
    Peter K Kaiser
    Cleveland Clinic, Cleveland, OH, USA
    Am J Ophthalmol 142:660-8. 2006
  3. ncbi request reprint Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results
    Peter K Kaiser
    Cole Eye Institute, Cleveland, OH 44195, USA
    Am J Ophthalmol 144:850-857. 2007
  4. pmc Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk i32, Cleveland, OH 44195, USA
    Graefes Arch Clin Exp Ophthalmol 250:1563-71. 2012
  5. doi request reprint Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study
    Peter K Kaiser
    Cleveland Clinic Foundation, Cleveland, OH, USA
    Ophthalmology 119:1001-10. 2012
  6. doi request reprint Ranibizumab for age-related macular degeneration
    Dilsher S Dhoot
    Cole Eye Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Expert Opin Biol Ther 12:371-81. 2012
  7. doi request reprint Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Matthew Ohr
    Cole Eye Institute, Cleveland Clinic, 9500 Euclid Ave, Desk i3, Cleveland, OH 44195, USA
    Expert Opin Pharmacother 13:585-91. 2012
  8. doi request reprint Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
    Peter K Kaiser
    Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ophthalmology 116:747-55, 755.e1. 2009
  9. ncbi request reprint Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ophthalmology 114:1868-75. 2007
  10. ncbi request reprint Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration
    P K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Curr Med Res Opin 23:477-87. 2007

Collaborators

Detail Information

Publications61

  1. ncbi request reprint Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8
    Peter K Kaiser
    Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Graefes Arch Clin Exp Ophthalmol 244:1132-42. 2006
    ....
  2. ncbi request reprint Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases
    Peter K Kaiser
    Cleveland Clinic, Cleveland, OH, USA
    Am J Ophthalmol 142:660-8. 2006
    ..To provide an overview of angiogenesis and vascular endothelial growth factor (VEGF) and discusses the development approach, safety, and efficacy results of current and emerging anti-VEGF therapies for ocular diseases...
  3. ncbi request reprint Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results
    Peter K Kaiser
    Cole Eye Institute, Cleveland, OH 44195, USA
    Am J Ophthalmol 144:850-857. 2007
    ....
  4. pmc Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk i32, Cleveland, OH 44195, USA
    Graefes Arch Clin Exp Ophthalmol 250:1563-71. 2012
    ..Emerging clinical evidence suggests safety differences exist between ranibizumab and bevacizumab...
  5. doi request reprint Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study
    Peter K Kaiser
    Cleveland Clinic Foundation, Cleveland, OH, USA
    Ophthalmology 119:1001-10. 2012
    ....
  6. doi request reprint Ranibizumab for age-related macular degeneration
    Dilsher S Dhoot
    Cole Eye Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Expert Opin Biol Ther 12:371-81. 2012
    ..Ranibizumab is an anti-VEGF agent that has established itself as the gold standard in the treatment of neovascular AMD. Herein, we review the pharmacology, pharmacokinetics, efficacy and safety of ranibizumab...
  7. doi request reprint Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Matthew Ohr
    Cole Eye Institute, Cleveland Clinic, 9500 Euclid Ave, Desk i3, Cleveland, OH 44195, USA
    Expert Opin Pharmacother 13:585-91. 2012
    ..Vascular endothelial growth factor (VEGF) has emerged as a key target of treatment, with inhibitors of VEGF being shown to arrest the angiogenic process and avoid the visual damage typically associated with its presence...
  8. doi request reprint Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
    Peter K Kaiser
    Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ophthalmology 116:747-55, 755.e1. 2009
    ..To assess outcomes for patients with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) treated with verteporfin photodynamic therapy (PDT) and bevacizumab...
  9. ncbi request reprint Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ophthalmology 114:1868-75. 2007
    ....
  10. ncbi request reprint Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration
    P K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Curr Med Res Opin 23:477-87. 2007
    ....
  11. doi request reprint Strategies for inhibiting vascular endothelial growth factor
    Peter K Kaiser
    Vitreoretinal Department, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA
    Retina 29:S15-7. 2009
    ..The complexity of this signaling pathway supports the development of combination treatments for optimal control of biologic functions...
  12. doi request reprint Overview of radiation trials for age-related macular degeneration
    Peter K Kaiser
    Cleveland Clinic, Cole Eye Institute, Cleveland, Ohio 44195, USA
    Retina 29:S34-5. 2009
    ..However, even though the modern delivery systems permit relatively low dosages, there are risks of radiotherapy to ocular tissue, and its role remains speculative, pending results of ongoing trials...
  13. doi request reprint Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial
    Peter K Kaiser
    Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Curr Med Res Opin 25:1853-60. 2009
    ..To determine whether verteporfin photodynamic therapy (PDT) can safely reduce the risk of vision loss in patients with subfoveal occult with no classic choroidal neovascularization (CNV) due to age-related macular degeneration...
  14. doi request reprint Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration
    Hajir Dadgostar
    Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Ophthalmology 116:1740-7. 2009
    ....
  15. doi request reprint RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic, Ohio, USA
    Am J Ophthalmol 150:33-39.e2. 2010
    ..Secondary objectives included assessment of anatomic changes in retinal thickness, size of CNV, and changes in visual acuity...
  16. ncbi request reprint Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Curr Med Res Opin 21:705-13. 2005
    ....
  17. ncbi request reprint Intravitreal bevacizumab for macular edema due to occlusive vasculitis
    Ron Margolis
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Semin Ophthalmol 22:105-8. 2007
    ..This effect persisted for at least 3 months after treatment. No complications, including increased retinal ischemia, were observed...
  18. ncbi request reprint Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy
    Darius M Moshfeghi
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 135:343-50. 2003
    ..To report the clinicopathologic findings after submacular removal of choroidal neovascular membranes (CNV) treated with verteporfin ocular photodynamic therapy...
  19. ncbi request reprint Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration
    Clement K Chan
    Southern California Desert Retina Consultants, Palm Springs, CA 92263, USA
    Retina 27:541-51. 2007
    ..Eyes with a vascularized pigment epithelial detachment (PED) that developed an RPE tear were compared with eyes with a vascularized PED but without an RPE tear...
  20. ncbi request reprint Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema
    Ron Margolis
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Acta Ophthalmol 86:105-10. 2008
    ....
  21. ncbi request reprint Treatment of Co-existent occult choroidal neovascular membrane and macular hole
    Rishi P Singh
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Surv Ophthalmol 52:547-50. 2007
    ..When treatment is entertained, therapy should be directed first toward the neovascular complex and then to repair the macular hole...
  22. doi request reprint Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections
    Clement K Chan
    Southern California Desert Retina Consultants, Palm Springs, California 92263, USA
    Retina 30:203-11. 2010
    ....
  23. doi request reprint Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab
    Kaori Sayanagi
    Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ophthalmology 116:947-55. 2009
    ....
  24. ncbi request reprint Verteporfin ocular photodynamic therapy
    Sophie J Bakri
    Cole Eye Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Expert Opin Pharmacother 5:195-203. 2004
    ..In addition, the safety profile and side effects of verteporfin are discussed...
  25. pmc Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study
    Oswaldo Ferreira Moura Brasil
    The Cleveland Clinic, Cole Eye Institute, Cleveland, Ohio 44195, USA
    Br J Ophthalmol 91:761-5. 2007
    ..To evaluate the predictive factors for visual outcome after intravitreal triamcinolone acetonide injection to treat refractory diabetic macular oedema (DME)...
  26. doi request reprint Assessing the reliability of automated OCT retinal thickness measurements in patients with choroidal neovascularization due to age-related macular degeneration
    Mehran Taban
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Ophthalmic Surg Lasers Imaging 41:166-74. 2010
    ..To compare automated versus manual retinal measurement using Stratus optical coherence tomography (OCT) (Carl Zeiss Meditec, Dublin, CA) in patients with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD)...
  27. ncbi request reprint Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection
    Darius M Moshfeghi
    Cole Eye Institute, The Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Ophthalmol 134:132-4. 2002
    ..To report a case of retinal and choroidal vascular occlusion occurring as a complication after posterior sub-Tenon triamcinolone injection for treatment of uveitic cystoid macular edema...
  28. ncbi request reprint Actinobacillus actinomycetemcomitans endogenous endophthalmitis: report of two cases and review of the literature
    Monica I Binder
    Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Scand J Infect Dis 35:133-6. 2003
    ..Eye specimen cultures should be incubated for 10 d. A thorough dental examination should be done in each patient and any periodontal disease should be promptly treated...
  29. ncbi request reprint Optical coherence tomographic patterns of diabetic macular edema
    Brian Y Kim
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Ophthalmol 142:405-12. 2006
    ..To describe various morphologic patterns of diabetic macular edema (DME) demonstrated by optical coherence tomography (OCT) and correlate them with visual acuity...
  30. doi request reprint Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements
    Mehran Taban
    Cole Eye Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Ophthalmology 116:964-70. 2009
    ....
  31. ncbi request reprint Spectral domain optical coherence tomography and fundus autofluorescence findings in pseudoxanthoma elasticum
    Kaori Sayanagi
    Cole Eye Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ophthalmic Surg Lasers Imaging 40:195-7. 2009
    ..SD-OCT combined with fundus autofluorescence imaging may be a useful tool for diagnosis of the atypical deposits in patients with pseudoxanthoma elasticum, which could lead to visual loss...
  32. ncbi request reprint Bilateral endogenous endophthalmitis caused by HACEK microorganism
    Preston Sullivan
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 133:144-5. 2002
    ..To report a case of bilateral endogenous endophthalmitis caused by a HACEK group organism (Actinobacillus actinomycetemcomitans)...
  33. ncbi request reprint Neovascular age-related macular degeneration: potential therapies
    Aimee V Chappelow
    Cole Eye Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Drugs 68:1029-36. 2008
    ..Other potential therapies include pigment epithelium-derived factor-based therapies, nicotinic acetylcholine receptor antagonists, integrin antagonists and sirolimus...
  34. pmc Role of ranibizumab in management of macular degeneration
    Rishi P Singh
    Cole Eye Institute, Cleveland Clinic Foundation, USA
    Indian J Ophthalmol 55:421-5. 2007
    ..These studies recommended monthly intravitreal ranibizumab for patients. However, the PIER study reported that an alternative dosing of every three months is acceptable but less effective than monthly injections...
  35. ncbi request reprint Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis
    Mehryar Taban
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 144:50-54. 2007
    ..To report an association between uveitis and sterile endophthalmitis after intravitreal triamcinolone acetonide injection...
  36. ncbi request reprint Vitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implant
    Anat Galor
    Cleveland Clinic Cole Eye Institute, 9500 Euclid Ave, Desk i32, Cleveland, OH 44195, USA
    Arch Ophthalmol 125:836-8. 2007
  37. ncbi request reprint Advances in AMD imaging
    Rishi Singh
    Cole Eye Institute Retina Service, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Int Ophthalmol Clin 47:65-74. 2007
  38. ncbi request reprint Vitrectomy for the diagnosis and management of uveitis of unknown cause
    Ron Margolis
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ophthalmology 114:1893-7. 2007
    ..To determine the diagnostic yield of tests commonly used for vitreous fluid analysis in eyes with suspected intraocular infection or malignancy...
  39. ncbi request reprint Choroidal hemangioma
    Arun D Singh
    Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ophthalmol Clin North Am 18:151-61, ix. 2005
    ..Diffuse choroidal hemangiomas are usually evident at birth and generally occur as a part of neuro-oculo-cutaneous hemangiomatosis (Sturge-Weber syndrome)...
  40. ncbi request reprint Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema
    Sophie J Bakri
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 4195, USA
    Am J Ophthalmol 139:290-4. 2005
    ..To evaluate posterior subtenon injection of triamcinolone acetonide for refractory diabetic macular edema (DME)...
  41. ncbi request reprint Occlusive vasculitis in a patient with concomitant West Nile virus infection
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 136:928-30. 2003
    ..To describe a patient with occlusive, retinal vasculitis and concomitant, confirmed, acute West Nile virus (WNV) infection...
  42. pmc Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis)
    Peter K Kaiser
    The Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, USA
    Trans Am Ophthalmol Soc 107:311-24. 2009
    ....
  43. ncbi request reprint Reopening of previously closed macular holes after cataract extraction
    Pawan Bhatnagar
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Am J Ophthalmol 144:252-9. 2007
    ..To evaluate the frequency of reopening of macular holes after cataract extraction...
  44. ncbi request reprint Multifocal posterior necrotizing retinitis
    Ron Margolis
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 143:1003-1008. 2007
    ..To describe the clinical features of an acute, inflammatory, and progressive retinal necrosis that affects primarily the posterior pole...
  45. ncbi request reprint Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center
    Monica I Binder
    Department of Infectious Disease, Cleveland Clinic Foundation, Ohio 44195, USA
    Medicine (Baltimore) 82:97-105. 2003
    ..Good visual outcome was associated with visual acuity of 20/200 or better at diagnosis and with the absence of hypopyon...
  46. doi request reprint Surgical drainage of chronic serous retinal detachment associated with uveitis
    Anat Galor
    Cole Eye Institute, The Cleveland Clinic Foundation, OH 44195, USA
    Retina 28:282-8. 2008
    ..To evaluate the anatomic and visual outcomes after surgical management of chronic serous retinal detachments (SRD) associated with uveitis...
  47. ncbi request reprint Branch retinal vein occlusion: clinical findings, natural history, and management
    Ron Margolis
    Cole Eye Institute, Cleveland, OH 44195, USA
    Compr Ophthalmol Update 7:265-76. 2006
    ....
  48. ncbi request reprint Posterior juxtascleral depot administration of anecortave acetate
    Peter K Kaiser
    Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, Ohio 44195, USA
    Surv Ophthalmol 52:S62-9. 2007
    ....
  49. ncbi request reprint Retinal manifestations of cerebroretinal vasculopathy
    Ying Qian
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Semin Ophthalmol 22:163-5. 2007
    ..Hereditary small vessel disease of the brain and retina is a spectrum of different entities that has many manifestations in end organs outside of the central nervous system...
  50. doi request reprint Ocular complications in patients with lung transplants
    Ahmad B Tarabishy
    Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Br J Ophthalmol 95:1295-8. 2011
    ..To describe infectious and non-infectious ocular complications found in patients with lung transplants...
  51. doi request reprint Comparison of retinal thickness measurements between three-dimensional and radial scans on spectral-domain optical coherence tomography
    Kaori Sayanagi
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 148:431-8. 2009
    ..To compare retinal thickness (RT) measurements between traditional 6 radial line scans and three-dimensional (3D) scans using spectral-domain optical coherence tomography (SD-OCT)...
  52. doi request reprint Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide
    Terri L McKay
    Research and Technology Directorate and National Center for Space Exploration Research, NASA Glenn Research Center, Cleveland, Ohio 44135, USA
    Invest Ophthalmol Vis Sci 49:1184-90. 2008
    ..To quantify the effects of the steroid triamcinolone acetonide (TA) on branching morphology within the angiogenic microvascular tree of the chorioallantoic membrane (CAM) of quail embryos...
  53. ncbi request reprint A novel mutation in the RDS/Peripherin gene causes adult-onset foveomacular dystrophy
    Zhenglin Yang
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Ophthalmol 135:213-8. 2003
    ..To describe a novel mutation in the RDS/Peripherin gene that results in a moderately severe form of adult-onset foveomacular dystrophy...
  54. pmc Cystoid puncture for chronic cystoid macular oedema
    Rishi P Singh
    Digital Optical Coherence, Tomography Reading Center DOCTR, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Br J Ophthalmol 91:1062-4. 2007
    ..To evaluate the new surgical technique of cystoid macular oedema puncture (CMOP) in patients with longstanding cystoid macular oedema refractory to standard treatments...
  55. doi request reprint Evaluation of wound closure in oblique 23-gauge sutureless sclerotomies with visante optical coherence tomography
    Mehran Taban
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Ophthalmol 147:101-107.e1. 2009
    ..To investigate the in vivo real-time wound morphology of fresh 23-gauge sutureless oblique sclerotomy wounds with anterior segment optical coherence tomography (OCT)...
  56. doi request reprint Scleral thickness following fluocinolone acetonide implant (Retisert)
    Mehran Taban
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ocul Immunol Inflamm 18:305-13. 2010
    ..To evaluate whether intravitreal fluocinolone acetonide (FA) implantation (Retisert) leads to scleral thinning...
  57. doi request reprint Dynamic evaluation of sutureless vitrectomy wounds: an optical coherence tomography and histopathology study
    Mehran Taban
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ophthalmology 115:2221-8. 2008
    ..To investigate the in vitro dynamic wound morphology of fresh 25- and 23-gauge sutureless sclerotomy wounds...
  58. pmc Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers
    Jiayin Gu
    Cole Eye Institute, Lerner Research Inst, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Mol Cell Proteomics 8:1338-49. 2009
    ..We conclude that CEP plasma biomarkers, particularly in combination with genomic markers, offer a potential early warning system for assessing susceptibility to this blinding, multifactorial disease...
  59. pmc Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration analysis (VESGEN)
    Patricia Parsons-Wingerter
    National Aeronautics and Space Administration, John H Glenn Research Center, Cleveland, Ohio 44135, USA
    Invest Ophthalmol Vis Sci 51:498-507. 2010
    ..The purpose of this study was to map and quantify vascular changes during progression of DR by VESsel GENeration Analysis (VESGEN)...
  60. pmc Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration
    Jiaqian Ni
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mol Cell Proteomics 8:1921-33. 2009
    ....
  61. ncbi request reprint Anecortave acetate
    Sophie J Bakri
    Cole Eye Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk i3, Cleveland, OH 44195, USA
    Expert Opin Investig Drugs 15:163-9. 2006
    ..It also discusses ongoing clinical trials involving anecortave acetate for dry and wet age-related macular degeneration...

Research Grants2

  1. Vacsular Remodeling and Effects of Angiogenic Inhibition in Diabetic Retinopathy
    Peter Kaiser; Fiscal Year: 2006
    ..The CAM continues to serve as a convenient testbed for ongoing development of fractal methods and for examination of effects of human regulators on angiogenesis and vascular remodeling. ..